- Home
- MTDR vs HALO Comparison
MTDR vs HALO Comparison
Compare MTDR & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTDR
- HALO
- Stock Information
- Founded
- MTDR 2003
- HALO 1998
- Country
- MTDR United States
- HALO United States
- Employees
- MTDR N/A
- HALO N/A
- Industry
- MTDR Oil & Gas Production
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MTDR Energy
- HALO Health Care
- Exchange
- MTDR Nasdaq
- HALO Nasdaq
- Market Cap
- MTDR 7.1B
- HALO 6.4B
- IPO Year
- MTDR 2012
- HALO N/A
- Fundamental
- Price
- MTDR $62.74
- HALO $55.94
- Analyst Decision
- MTDR Strong Buy
- HALO Buy
- Analyst Count
- MTDR 14
- HALO 9
- Target Price
- MTDR $75.43
- HALO $60.89
- AVG Volume (30 Days)
- MTDR 1.1M
- HALO 1.6M
- Earning Date
- MTDR 02-18-2025
- HALO 02-18-2025
- Dividend Yield
- MTDR 1.60%
- HALO N/A
- EPS Growth
- MTDR 7.36
- HALO 61.71
- EPS
- MTDR 7.55
- HALO 3.02
- Revenue
- MTDR $3,099,645,000.00
- HALO $947,355,000.00
- Revenue This Year
- MTDR $34.29
- HALO $23.12
- Revenue Next Year
- MTDR $18.78
- HALO $15.48
- P/E Ratio
- MTDR $8.30
- HALO $18.13
- Revenue Growth
- MTDR 23.82
- HALO 21.35
- 52 Week Low
- MTDR $47.15
- HALO $33.15
- 52 Week High
- MTDR $71.08
- HALO $65.53
- Technical
- Relative Strength Index (RSI)
- MTDR 66.82
- HALO 70.48
- Support Level
- MTDR $62.54
- HALO $52.23
- Resistance Level
- MTDR $63.99
- HALO $55.79
- Average True Range (ATR)
- MTDR 1.54
- HALO 1.59
- MACD
- MTDR 0.59
- HALO 0.71
- Stochastic Oscillator
- MTDR 86.67
- HALO 94.93
About MTDR Matador Resources Company
Matador Resources Co is an independent energy company engaged in the exploration, development, production, and acquisition of oil and natural gas resources. The majority of the company's assets are located in the United States, with an emphasis on oil and natural gas shale and other unconventional plays. Along with maintaining a portfolio of oil and natural gas properties, Matador works to identify and develop midstream opportunities that support and enhance its exploration and development business.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.